Scanner DailyTickers — Tuesday, May 13, 2026

Apple is breaking to new all-time highs ($294.80) on iPhone 17 pre-cycle momentum and Services revenue acceleration past $100B annual run rate. Apple Intelligence AI integration is driving the strongest upgrade cycle expectations since iPhone 12. The stock trades 4.7% above its 50-DMA with sustained institutional volume confirming the breakout. Services gross margins expanding above 75% create a secular re-rating story. CPI Tuesday is the key risk — benign print greenlights mega-cap tech continuation, hot print triggers a 2-3% pullback that our stop at $278 absorbs.

UnitedHealth near ATH ($396.39) as the largest managed care company benefits from Medicare Advantage enrollment growth and Optum Health margin expansion. This is a CPI-resilient defensive play — healthcare spending is non-discretionary regardless of inflation outcome. Trading 8.5% above 50-DMA with active BUY signal. Optum Rx and Optum Health segments provide diversified revenue growth across pharmacy benefits, care delivery, and health data analytics. Forward PE ~20x is reasonable for consistent 13-15% EPS growth.

SMH captures the broadest semiconductor rally since the AI cycle began in 2023. Top holdings NVDA, AVGO, AMD, QCOM all at or near ATH. The key development: rally is widening beyond NVDA into memory (MU +6.5%), interconnects (GLW +10.9%), and foundry (INTC +3.6%). This breadth expansion is the strongest bullish signal for sector sustainability. SMH provides diversified semi exposure with lower single-stock risk than individual names. Cisco Q3 earnings Thursday provide next AI networking catalyst.

Fortinet sustaining its ATH breakout from the May 12 scan ($113.87). Cybersecurity spending is structurally non-discretionary — enterprise budgets prioritize security regardless of macro outlook. FortiAI platform driving ARPU expansion as AI-powered security operations centers become standard. Firewall refresh cycle re-accelerating billings growth. Repeat pick — momentum confirmed with continued institutional accumulation and no distribution signals.

SLB is the highest-conviction energy play as WTI crude surges +4.27% to $102.26 on Middle East supply concerns. As the world's largest oilfield services company, SLB benefits directly from upstream capex acceleration — every $10 oil move translates to ~15% earnings sensitivity. International revenue diversification (80% non-US) provides DXY weakness tailwind. Critically, SLB serves as a natural CPI hedge: if CPI runs hot due to oil, SLB benefits. If CPI is cool, the risk-on regime supports the broader portfolio.

Goldman Sachs at ATH ($945.90) on the strongest investment banking recovery since 2021. M&A advisory pipeline is at multi-year highs as corporate confidence returns post-rate-clarity. FICC trading revenues surging on geopolitical volatility and cross-asset repricing. Capital markets reopening driving IPO and debt issuance fees. Forward PE ~13x is historically cheap for best-in-class ROE (19%+). GS provides defensive financial sector exposure — benefits from both risk-on (IB fees) and volatility (trading revenues).

TotalEnergies momentum sustained near ATH ($91.76) with oil at $102+ providing direct earnings tailwind. Integrated energy model differentiates from pure E&P: diversified across oil, LNG, renewables, and power marketing. 4%+ dividend yield provides downside cushion. EU energy security premium post-Russia decoupling remains structural. Repeat pick from May 12 scan — trend confirmed with continued DXY weakness at $98 amplifying EUR-denominated returns for US-listed ADR investors.

Costco at ATH ($1,021.88) as the membership-model retail champion proves recession-proof. Same-store sales growth accelerating as value-seeking consumer behavior intensifies. E-commerce penetration rising with Instacart partnership and Costco Logistics. This is a CPI-agnostic play: inflation drives more consumers to warehouse clubs for value, while deflation supports discretionary spending. Membership renewal rates above 93% create predictable revenue visibility. PE premium justified by best-in-class unit economics.

Novo Nordisk is the best value entry in the GLP-1 megatrend at FwdPE 13.7x — a massive discount to peer LLY (~50x). Wegovy and Ozempic revenue growth accelerating as manufacturing capacity constraints ease. CagriSema next-generation obesity drug data imminent as a re-rating catalyst. The pullback from highs creates a defined entry zone with support at $43.50. Repeat pick from May 12 — thesis intact, entry zone holding, international diversification benefit from DXY weakness.

iShares Taiwan ETF near ATH ($93.77) driven by TSMC earnings strength and global AI chip demand surge. TSMC constitutes 60%+ of ETF weight, making EWT a leveraged proxy for AI semiconductor infrastructure without single-stock concentration risk. Taiwan semiconductor exports at record levels. DXY weakness at $98 amplifies TWD-denominated returns. Provides essential APAC diversification in a portfolio otherwise US/EU-heavy. Cisco Q3 earnings Thursday is the next AI networking catalyst for the broader semi ecosystem.